Plain-English translation of NCT06551311 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether eccentric cycling exercise—a type of exercise where muscles lengthen while working—can help people with chronic kidney disease. Researchers will compare eccentric cycling to regular cycling and to usual care alone to see which helps most with muscle strength, physical fitness, and overall quality of life.
People with chronic kidney disease often lose muscle mass and strength, which makes daily activities harder and reduces quality of life. This medication hasn't been studied in this way before, so researchers want to find out if this special type of exercise could be a helpful, natural way to prevent these problems.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll be randomly assigned to one of three groups: regular care only, regular cycling exercise three times per week for eight weeks, or eccentric cycling exercise three times per week for eight weeks. Each exercise session lasts 20 to 30 minutes. The research team will check your muscle strength, physical function, breathing, and kidney health before and after the program.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Taiwan
Sponsor
National Cheng Kung University
Enrollment target
~90 participants
Started
July 2023
Primary completion
June 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
55 Years – 85 Years
Last updated on clinicaltrials.gov in December 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Kun-Ling Tsai, Ph.D.
National Cheng Kung University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.